Genetic Signatures is a specialist molecular diagnostics (MDx) company focused on the development and commercialisation of its proprietary platform technology, 3Base™.

Genetic Signatures has developed and commercialised a suite of real time PCR based products which are now being used by major hospitals in Australia for the routine detection of infectious diseases. The Company's proprietary MDx technology provides high-volume hospitals and pathology laboratories with the ability to screen for a wide array of infectious pathogens with a high degree of specificity in a rapid throughput (time to result) environment.